Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Cancer Chemotherapy and Pharmacology|October 7, 2019
Correction to: Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trialFernando Rivera, C Romero, P Jimenez-Fonseca, et al.
Cancer Chemotherapy and Pharmacology|March 31, 2019
Phase II study to evaluate the efficacy of Trastuzumab in combination with Capecitabine and Oxaliplatin in first-line treatment of HER2-positive advanced gastric cancer: HERXO trialFernando Rivera, C Romero, P Jimenez-Fonseca, et al.
ESMO Gastrointestinal Oncology|May 25, 2026
Dose optimization of immune checkpoint inhibitors for gastrointestinal malignanciesM Alsina, M Beunza-Sola, A Fernández-Montes, et al.
Oral Oncology|April 22, 2017
Multidisciplinary management of head and neck cancer: First expert consensus using Delphi methodology from the Spanish Society for Head and Neck Cancer (part 1)M Mañós, J Giralt, A Rueda, et al.
The Journal of Nutrition, Health & Aging|November 14, 2023
Tailored Prevention of Functional Decline through a Multicomponent Exercise Program in Hospitalized Oncogeriatric Patients: Study Protocol for a Randomized Clinical TrialN Martínez-Velilla, V Arrazubi, F Zambom-Ferraresi, et al.
BMC Cancer|June 2, 2024
The TEOGIC study project: a comprehensive characterization of early onset gastrointestinal cancer in the Northern area of SpainR Vera, N Castro, I Labiano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE studyF Lordick, M E Mauer, G Stocker, et al.
Pageof 2